Evidence map›Paper›PMID 21858133›Full record

ArticlePloS one2011

Disparate associations of HLA class I markers with HIV-1 acquisition and control of viremia in an African population.

Wei Song, Dongning He, Ilene Brill, Rakhi Malhotra, Joseph Mulenga, Susan Allen, Eric Hunter, Jianming Tang, Richard A Kaslow

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Association of HLA alleles (A, B, DRB1) and HIV-1 infection in the Han population of Hubei, China.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2017
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Wei SongDepartment of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Dongning He
Ilene Brill
Rakhi Malhotra
Joseph Mulenga
Susan Allen
Eric Hunter
Jianming Tang
Richard A Kaslow
University of Alabama at Birmingham · USRwanda Zambia HIV Research Group · RWEmory University · US

Funding

CTL and HIV Polymorphisms in Heterosexual TransmissionR01AI064060 · NIAID · EMORY UNIVERSITY · PI GOEPFERT, PAUL A., HUNTER, ERIC · 2005 to 2019
$21.7M
Host Genetic Epidemiology in HIV-1-Discordant African Couples and Other CohortsR01AI071906 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI TANG, JIANMING · 2008 to 2012
$3.8M
HETEROSEXUAL TRANSMISSION AND THE NATURAL HISTORY OF HIVR01AI040951 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ALLEN, SUSAN A. · 1996 to 2000
$1.2M
Heterogeneity in Cytokine Responses to HIV-1 InfectionK02AI076123 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI TANG, JIANMING · 2007 to 2011
$602k
NIAID NIH HHS AI040951NIAID NIH HHS AI064060NIAID NIH HHS AI071906NIAID NIH HHS AI076123NIAID NIH HHS K02 AI076123NIAID NIH HHS R01 AI064060NIAID NIH HHS R01 AI071906
6 · The paper itself

Abstract

backgroundAcquisition of human immunodeficiency virus type 1 (HIV-1) infection is mediated by a combination of characteristics of the infectious and the susceptible member of a transmission pair, including human behavioral and genetic factors, as well as viral fitness and tropism. Here we report on the impact of established and potential new HLA class I determinants of heterosexual HIV-1 acquisition in the HIV-1-exposed seronegative (HESN) partners of serodiscordant Zambian couples. METHODOLOGY/PRINCIPAL

findingsWe assessed the relationships of behavioral and clinically documented risk factors, index partner viral load, and host genetic markers to HIV-1 transmission among 568 cohabiting couples followed for at least nine months. We genotyped subjects for three classical HLA class I genes known to influence immune control of HIV-1 infection. From 1995 to December 2006, 240 HESNs seroconverted and 328 remained seronegative. In Cox proportional hazards models, HLA-A*68:02 and the B*42-C*17 haplotype in HESN partners were significantly and independently associated with faster HIV-1 acquisition (relative hazards = 1.57 and 1.55; p = 0.007 and 0.013, respectively) after controlling for other previously established contributing factors in the index partner (viral load and specific class I alleles), in the HESN partner (age, gender), or in the couple (behavioral and clinical risk score). Few if any previously implicated class I markers were associated here with the rate of acquiring infection. CONCLUSIONS/SIGNIFICANCE: A few HLA class I markers showed modest effects on acquisition of HIV-1 subtype C infection in HESN partners of discordant Zambian couples. However, the striking disparity between those few markers and the more numerous, different markers found to determine HIV-1 disease course makes it highly unlikely that, whatever the influence of class I variation on the rate of infection, the mechanism mediating that phenomenon is identical to that involved in disease control.

Indexed as

AdultBlack PeopleFemaleGene FrequencyGenotypeHaplotypesHealth SurveysHeterosexualityHIV-1HIV InfectionsHIV SeronegativityHLA-A AntigensHLA AntigensHLA-B AntigensHumansMaleHLA-A*68 antigenHLA-A AntigensHLA AntigensHLA-B Antigens

Identifiers

PMID21858133
PMCPMC3157381
OpenAlexW2016901250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.